PO.TB10.14 · 肿瘤生物学
利用单细胞转录组学绘制结直肠癌中肿瘤内细菌的细胞图谱
Mapping the cellular landscape of intratumoral bacteria in colorectal cancer using single-cell transcriptomics
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
肿瘤相关微生物正日益受到各类癌症研究的关注。在CRC中,肿瘤内微生物与不良的治疗反应和临床结局相关。然而,对于TME内单个细胞如何应对微生物存在,仍存在关键的认识空白。明确这些细胞反应有望为癌症中微生物-宿主相互作用提供机制性见解,并揭示新的治疗靶点。
为绘制CRC中肿瘤内细菌的细胞图谱,我们开发了一套将单细胞转录组学与宏基因组分析相结合的定制分析流程。我们对来自146例CRC患者的150份样本进行了scRNA-seq,涵盖85例原发肿瘤、60例肝转移和5例腹膜转移。使用Seurat 5.1.0进行无监督聚类,并利用PanglaoDB和经典标志物对细胞进行注释。将单细胞reads汇总后比对NCBI和SILVA数据库。
从650,485个细胞的1.09x10^9条reads起始,我们应用了严格的质量过滤,包括修剪、人类基因组过滤(去除98.7%的reads)以及一个用于排除可能污染物的定制k-mer多样性过滤器。这一最终过滤器剔除了96%的剩余reads和92%的最初鉴定出的分类单元,解决了scRNA-seq数据中环境污染的难题。我们的流程最终保留了来自4,888个细胞(0.8%)的18,115条高置信度细菌reads(<占总数的0.001%),代表1,237个独特分类单元。在排除污染物后,我们鉴定出跨48个属的89个物种,包括Bacteroides fragilis、Parvimonas micra、Gemella morbillorum和Fusobacterium nucleatum。通过条形码将细菌reads映射到细胞。聚类鉴定出16个细胞群,其细菌信号涵盖所有主要细胞类型和肿瘤部位。在这项探索性单细胞分析中,原发结肠肿瘤的细胞与肝转移的细胞相比表现出更高的细菌多样性(p<0.01)。在原发结肠肿瘤中,MSI-H肿瘤(n=15)的细胞展现出显著高于MSS肿瘤(n=67)的细菌reads(95% CI [2.425, 12.691],p = 0.006)。此外,原发结肠肿瘤中细菌阳性细胞的存在,与无可检出细胞内细菌的肿瘤相比,与显著更差的患者生存相关(HR 4.90,95% CI [1.08, 22.2],p = 0.039)。
我们的发现表明,尽管细菌reads的丰度极低,但在应用严格的污染控制时,仍可从scRNA-seq数据中检索出来。所达到的分类学分辨率为在单细胞分辨率下研究微生物-宿主相互作用提供了概念验证。本研究为利用单细胞技术探究肿瘤及其微生物组之间的复杂相互作用奠定了方法学基础。
查看英文原文 English abstract
Tumor-associated microbes are increasingly investigated across cancer types. In CRC, intratumoral microbes are associated with detrimental treatment responses and clinical outcomes. However, critical gaps remain in understanding how individual cells within the TME respond to microbial presence. Defining these cellular responses could provide mechanistic insights into microbe-host interactions in cancer and reveal novel therapeutic targets.
To map the cellular landscape of intratumoral bacteria in CRC, we developed a custom analytical pipeline integrating single-cell transcriptomics with metagenomic profiling. We performed scRNA-seq on 150 samples from 146 CRC patients across 85 primary tumors, 60 liver metastases, and 5 peritoneal metastases. Unsupervised clustering was performed using Seurat 5.1.0, with cells annotated using PanglaoDB and canonical markers. Single-cell reads were aggregated and mapped against NCBI and SILVA databases.
Starting with 1.09x10 9 reads from 650,485 cells, we applied stringent quality filters including trimming, human genome filtering (removing 98.7% of reads), and a custom k-mer diversity filter to exclude likely contaminants. This final filter eliminated 96% of remaining reads and 92% of initially identified taxonomies, addressing the challenge of ambient contamination in scRNA-seq data. Our pipeline ultimately retained 18,115 high-confidence bacterial reads (<0.001% of total) from 4,888 cells (0.8%), representing 1,237 unique taxa. After contaminant exclusion, we identified 89 species across 48 genera, including Bacteroides fragilis, Parvimonas micra, Gemella morbillorum, and Fusobacterium nucleatum. Bacterial reads were mapped to cells using barcodes. Clustering identified 16 cell populations with bacterial signals across all major cell types and tumor sites. In this exploratory single-cell analysis, cells from primary colon tumors exhibited increased bacterial diversity compared to cells from liver metastases (p<0.01). Within primary colon tumors, cells from MSI-H tumors (n=15) demonstrated significantly higher bacterial reads than cells from MSS tumors (n=67, 95% CI [2.425, 12.691], p = 0.006). Furthermore, the presence of bacteria-positive cells in primary colon tumors was associated with significantly worse patient survival compared to tumors without detectable intracellular bacteria (HR 4.90, 95% CI [1.08, 22.2], p = 0.039).
Our findings demonstrate that bacterial reads, although present at extremely low abundance, can be retrieved from scRNA-seq data when stringent contamination controls are applied. The taxonomic resolution achieved provides proof-of-concept for investigating microbe-host interactions at single-cell resolution. This study establishes a methodological foundation for leveraging single-cell technologies to probe the complex interplay between tumors and their microbiome.
利益披露 Disclosure
I. W. Folkert, None..
A. Day, None..
A. Damania, None..
M. C. Wong, None..
T. Neilson, None..
R. Morgan, None..
J. Smith, None..
N. J. Ajami, None..
J. P. Shen, None.